Alzheimer's Disease

• S8007

  Substance P (1-7)

  Endogenous tachykinin peptide, involved in infl...

  ≥95%
• S8008

  Substance P (1-9)

  Endogenous tachykinin peptide, involved in infl...

  ≥95%
• S8009

  Substance P (7-11)

  Endogenous tachykinin peptide, involved in infl...

  ≥95%
• S8014

  Substance P, Free Acid

  Endogenous tachykinin peptide, involved in infl...

  ≥95%
• T0249

  Tamibarotene

  RARα/β agonist.

  ≥98%
• T0154

  Tanshinone IIA

  Found in Salvia; MAG lipase inhibitor.

  ≥93%
• U698574

  Urolithin A

  Ellagic acid derivative produced by gut microfl...

  ≥98%
• U698576

  Urolithin B

  Ellagic acid derivative produced by gut microfl...

  ≥99%
• U698578

  Urolithin C

  Ellagic acid derivative produced by gut microfl...

  ≥98%
• V014451

  Valiltramiprosate

  beta-Amyloid anti-oligomer and aggregation inhi...

  ≥99%
• V024761

  Vatalanib

  Inhibitor of VEGFR1/2/3.

  ≥98%
• V182705

  Verubecestat

  BACE1 inhibitor

  ≥98%
• V3345

  Vildagliptin

  DPP4 inhibitor.

  ≥98%
• Z3444

  Zileuton

  5-Lipoxygenase inhibitor.

  ≥98%
• M7528

  α-Melanocyte Stimulating Hormone

  Endogenous peptide hormone derived from POMC, i...

  ≥98%
• Z161022

  α-Zearalanol

  Mycotoxin that has structural similarity to est...

  ≥98%
• Z161024

  α-Zearalenol

  Mycotoxin that has structural similarity to est...

  ≥98%
• A4852

  β-Amyloid Peptide (1-40)

  Endogenous APP peptide cleavage product, primar...

  ≥95%
• A4851

  β-Amyloid Peptide (1-40), rat

  Endogenous APP peptide cleavage product, primar...

  ≥95%
• A4853

  β-Amyloid Peptide (1-42), human

  Endogenous APP peptide cleavage product, primar...

  ≥95%
• A4854

  β-Amyloid Peptide (1-42), rat

  Endogenous APP peptide cleavage product, primar...

  ≥95%
• Z161023

  β-Zearalanol

  Mycotoxin that has structural similarity to est...

  ≥98%
• Z161025

  β-Zearalenol

  Mycotoxin that has structural similarity to est...

  ≥98%

Showing 126–148 of 148 results